Premium
Subcutaneous injection of thymopentin in the area of the supramammary lymph node to reduce milk somatic cell count in subclinically mastitic cows
Author(s) -
Guan R.,
Xu W.,
Pan T.,
Su X.,
Hu S.
Publication year - 2016
Publication title -
journal of veterinary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.527
H-Index - 60
eISSN - 1365-2885
pISSN - 0140-7783
DOI - 10.1111/jvp.12234
Subject(s) - somatic cell count , mastitis , lymph node , subcutaneous injection , medicine , thymopentin , somatic cell , lymph , zoology , biology , pathology , lactation , pregnancy , biochemistry , genetics , ice calving , gene
The objective of this study was to evaluate the therapeutic effects of thymopentin ( TP ‐5) injections on subclinical intramammary infection ( IMI ) in lactating cows. In Experiment I, 40 cows were randomly divided into four groups. The cows in groups 1, 2, and 3 received subcutaneous injections of TP ‐5 in the region of the supramammary lymph node at doses of 1, 2, and 4 mg, respectively, for 3 days. In Experiment II, 20 cows were randomly divided into two groups. The cows in group 1 were treated with injections of TP ‐5 (4 mg) for 3 days in the same area as in Experiment I. Group 4 in Experiment I and group 2 in Experiment II were not treated and served as control groups. Milk samples were collected before and after treatment for bacteriological examination and analysis of the somatic cell count and level of N ‐acetyl‐β‐ d ‐glucosaminidase ( NAG ase). The results showed that treatment with TP ‐5 significantly reduced the somatic cell count ( SCC ) and NAG ase activity of the milk and numerically reduced IMI . A dose of 4 mg was found to be optimal for the reduction of SCC and NAG ase in milk. Therefore, further study of the use of TP ‐5 in the treatment of bovine mastitis is warranted.